Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC

Clinical trial NCT06868732 · RECRUITING

Trial details

NCT number: NCT06868732
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer

Start date: 2025-04-02
Primary completion: 2028-06-30
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.